Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide activates both GLP-1 and GIP receptors, reducing appetite and improving glucose control, while NAD+ supports mitochondrial function and cellular energy production. When combined thoughtfully, these compounds may work synergistically to enhance weight loss outcomes and metabolic recovery. Understanding how to stack them safely requires clarity on mechanism, timing, and individual response patterns.
Start a NAD+ protocol with PlexusDx
One all-inclusive price covers your online provider visit, prescription, medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.
Start your intake →
How NAD+ and Tirzepatide Work Together
Tirzepatide reduces caloric intake and normalizes blood sugar through dual GLP-1/GIP signaling, which typically leads to rapid weight loss in the first 12 weeks. NAD+ is a coenzyme essential for energy metabolism, DNA repair, and mitochondrial efficiency—processes often depleted during aggressive caloric restriction. When tirzepatide suppresses appetite, the body may enter a state of reduced nutrient intake; NAD+ supplementation can help preserve cellular energy and reduce fatigue during this transition.
The combination targets two different biological systems: tirzepatide manages hunger and glucose metabolism through hormonal pathways, while NAD+ optimizes the energy-producing machinery inside cells. This approach may reduce the metabolic slowdown that sometimes occurs with weight loss, allowing users to maintain higher activity levels and better preserve lean muscle mass. Clinical research on NAD+ restoration in metabolically stressed states suggests improvements in insulin sensitivity and mitochondrial function within 8–12 weeks of consistent use.
NAD+ Dosing and Timing With Tirzepatide Injection
Most NAD+ protocols use either direct NAD+ precursors (nicotinamide riboside, NR, or nicotinamide mononucleotide, NMN) at 250–500 mg daily, or niacin-based approaches at 500–2000 mg daily. Tirzepatide injections are dosed once weekly, with dose escalation occurring every 4 weeks—independent of NAD+ supplementation. The two compounds do not interact pharmacologically, so timing is largely about convenience: take NAD+ with food in the morning, and administer your tirzepatide injection on the same day each week as scheduled.
Some individuals find that starting NAD+ supplementation 1–2 weeks before beginning tirzepatide reduces adjustment-phase side effects like nausea or fatigue. Others initiate both simultaneously without issue. Individual response varies based on baseline NAD+ status, age, and metabolic health—factors that PlexusDx's Precision Peptide Genetic Test can help clarify by mapping your peptide-pathway genes and metabolic predispositions.
Safety, Contraindications, and Monitoring
Tirzepatide and NAD+ are generally well tolerated when used together, but several precautions apply. NAD+ precursors can trigger flushing, particularly niacin-based forms, and may raise uric acid levels in people with gout history. Tirzepatide carries FDA warnings around thyroid C-cell tumors in animal studies (not observed in humans) and pancreatitis risk, especially if you have gallbladder disease or prior pancreatitis. Before combining these therapies, disclose your complete medical history, including gastrointestinal surgery, kidney function, and any prior metabolic disorders.
Monitoring should include baseline liver and kidney function tests, lipid panels, and fasting glucose—ideally repeated at 8 and 16 weeks. NAD+ supplementation may slightly lower cholesterol and improve triglycerides, which compounds the metabolic benefit of tirzepatide. If you experience severe abdominal pain, persistent nausea, or signs of pancreatitis (upper-left abdominal tenderness, elevated amylase), stop both agents and seek immediate medical evaluation.
PlexusDx Tirzepatide Injection and Personalized NAD+ Strategy
PlexusDx provides compounded tirzepatide injection from licensed 503A pharmacies, at $289/mo month-to-month, or from $249/mo on the 6-month plan flat—your dose may increase over time, but your price will not. This transparent, commitment-tier model (flexible, standard, or priority) lets you scale without surprise costs. When combined with a personalized NAD+ protocol tailored to your genetic and metabolic profile, the result is a more comprehensive weight loss and metabolic restoration approach than either therapy alone.
The PlexusDx Precision Peptide Genetic Test ($298) analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
Can I really combine NAD+ supplements with tirzepatide injections without drug interactions?
Yes—tirzepatide and NAD+ work through completely different biological pathways and have no known pharmacological interactions. NAD+ is a cofactor for cellular energy and repair, while tirzepatide signals through GLP-1 and GIP receptors in the gut and brain. You can safely use both simultaneously; timing is a matter of convenience rather than clinical necessity.
Will NAD+ help prevent the fatigue I might experience on tirzepatide?
NAD+ supports mitochondrial function and ATP production, which can reduce energy depletion during appetite suppression and weight loss. Many users report less fatigue and better workout performance when NAD+ supplementation is added during the first 8–12 weeks of tirzepatide therapy. Individual results vary based on baseline metabolic health and genetic predisposition to NAD+ responsiveness.
How much does the NAD+ and tirzepatide stack cost at PlexusDx?
PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan) (with flat pricing - your price won't climbs). NAD+ supplementation is not provided by PlexusDx but is widely available over-the-counter at $20–$60 per month from supplement retailers. Total stack cost is typically $270–$310 monthly, depending on your NAD+ brand and formulation choice.
Are there any side effects or safety concerns when stacking NAD+ with tirzepatide?
Tirzepatide carries warnings around pancreatitis and nausea; NAD+ precursors can cause flushing and may raise uric acid. Together, they are safe for most people—but disclose all medical history, especially prior pancreatitis, gout, or kidney disease. Baseline and 8-week lab monitoring (kidney function, liver function, amylase) is recommended to catch any adverse changes early.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Enduring Impact of Semaglutide: How Long Does a Dose Last?
Can I Inject Ozempic Twice a Week? Exploring the Dosing Guidelines